Walker-256 (LLC-WRC 256) Cells
USD$550.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | The Walker-256 cell line is a rat carcinoma cell line that is widely used in cancer research, specifically in the study of tumor biology and chemotherapy. Originating from a mammary gland carcinoma of a rat, this cell line is particularly noted for its aggressive metastatic behavior, making it a valuable model for studying cancer progression and metastasis. It has been used extensively to investigate the mechanisms of tumor growth and the efficacy of anti-cancer drugs in vivo. Walker-256 cells are adaptable to various environments, allowing them to be grown in a number of different animal models, which helps in the study of cancer biology in a systemic context. This cell line is instrumental in pharmacological studies, particularly those related to the development and testing of new chemotherapy agents. Researchers use Walker-256 to assess drug-induced cytotoxicity and to explore the potential mechanisms of action of novel therapeutic compounds. Its robust use in research provides critical insights into the dynamics of tumor growth and the systemic effects of tumors on host physiology. |
|---|---|
| Organism | Rat |
| Tissue | Mammary gland |
| Disease | Adenocarcinoma of the rat mammary gland |
| Synonyms | LLC-WRC 256, LLC-WRC256, Walker/LLC-WRC 256, Walker-Ca.256, Walker 256, W256, Lilly Laboratories Culture-Walker Rat Culture 256 |
Characteristics
| Breed/Subspecies | Wistar |
|---|---|
| Age | Unspecified |
| Gender | Female |
| Growth properties | Suspension |
Regulatory Data
| Citation | Walker-256 (Cytion catalog number 500375) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 10116 |
| CellosaurusAccession | CVCL_3537 |
Biomolecular Data
Handling
| Culture Medium | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| Supplements | Supplement the medium with 10% heat-inactivated FBS, 0.01 mg/mL Insulin, 4.5 g/L glucose, 1 mM Sodium pyruvate and 10 mM HEPES |
| Subculturing | Maintain cultures by periodically adding or replacing the medium. Initiate cultures with a density of 5 x 105 cells/ml and keep the cell concentration within the range of 3 x 105 to 1 x 106 cells/ml for optimal growth. |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 500375-300725 | Certificate of Analysis | 22. Oct. 2025 | 500375 |